Side Effects from Drugs used in Dialysis
GranuFIo – GranuFlo@ and NaturaLyte@ are products used in the dialysis process. On June 27, 2012, the FDA issued a Class l recall of GranuFlo@ and NaturaLyte@. A Class 1 recall is the most serious FDA recall, reserved for situations in which the FDA deems “there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. Use of these dialysis products has been linked to an increased risk of cardiopulmonary arrest and sudden cardiac death. The manufacturer, Fresenius Medical Care, was aware of the dangers and injuries associated with these products but failed to warn patients and doctors until 2012. We are currently investigating death claims as well as claims of heart attack, cardio pulmonary arrest or any other serious injury.
Use of GranuFlo and NaturaLyte by patients with elevated pre-dialysis bicarbonate blood levels, puts them at risk for severe side effects that include:
- Heart attack
- Myocardial infarction
- Sudden Death
- Low blood pressure (hypotension)
- Stroke
- Metabolic alkalosis
- Cardiopulmonary arrest